206 related articles for article (PubMed ID: 15704683)
81. Endocrine patterns in patients with benign and malignant prostatic diseases.
Schatzl G; Reiter WJ; Thürridl T; Waldmüller J; Roden M; Söregi S; Madersbacher S
Prostate; 2000 Aug; 44(3):219-24. PubMed ID: 10906738
[TBL] [Abstract][Full Text] [Related]
82. [Serum sex hormone and urinary metabolites of male workers exposed to carbon disulfide].
Wang C; Bi Y; Tan X; Yan J
Wei Sheng Yan Jiu; 1999 May; 28(3):132-3. PubMed ID: 12712711
[TBL] [Abstract][Full Text] [Related]
83. [Treatment of bladder neck adenoma].
Albert L; Baumann W
Z Arztl Fortbild (Jena); 1971 Mar; 65(5):257-61. PubMed ID: 4104076
[No Abstract] [Full Text] [Related]
84. Relationship between serum sex hormones levels and degree of benign prostate hyperplasia in Chinese aging men.
Zeng QS; Xu CL; Liu ZY; Wang HQ; Yang B; Xu WD; Jin TL; Wu CY; Huang G; Li Z; Wang B; Sun YH
Asian J Androl; 2012 Sep; 14(5):773-7. PubMed ID: 22751417
[TBL] [Abstract][Full Text] [Related]
85. [Modified Madigan prostatectomy].
Lü J; Cao QY; Wang W; Deng ZX; Huang XT; Nie HB; Wang YL; Hu WL; He HX; Ye LY
Zhonghua Wai Ke Za Zhi; 2003 Oct; 41(10):760-2. PubMed ID: 14766050
[TBL] [Abstract][Full Text] [Related]
86. Prostatectomy--induced decrease in an enhanced serum testosterone concentration in patients with prostatic hyperplasia and its pathophysiological implications.
Baranowska B; Zgliczyński S
Endokrynol Pol; 1979; 30(1):75-87. PubMed ID: 85550
[No Abstract] [Full Text] [Related]
87. Peripheral and prostatic vein steroid concentrations in benign prostatic hypertrophy patients before and after removal of the adenoma.
Lukkarinen O; Hammond GL; Kontturi M; Vihko R
Scand J Urol Nephrol; 1980; 14(3):225-7. PubMed ID: 6163202
[TBL] [Abstract][Full Text] [Related]
88. [Dynamics of the changes in sex hormones after renal transplant].
Orsoni G; Vangelista A; Buscaroli A; Capelli M; Fatone F; Docci D; Bonomini V
Minerva Nefrol; 1981; 28(1):81-3. PubMed ID: 6793944
[No Abstract] [Full Text] [Related]
89. [Pathogenesis and norsteroid treatment of bladder neck adenoma (prostatic hypertrophy)].
Magyarsóky F
Acta Chir Acad Sci Hung; 1973 Aug; 14(3):209-22. PubMed ID: 4129777
[No Abstract] [Full Text] [Related]
90. [Histomorphological studies on hyperplastic prostate of castrated rat caused by androgen].
Wang Y; Shao JC; Zhang SW
Zhonghua Nan Ke Xue; 2002; 8(3):190-3. PubMed ID: 12478841
[TBL] [Abstract][Full Text] [Related]
91. [Treatment of prostatic hypertrophy in persons over 70].
Potempa J
Ther Ggw; 1966 Oct; 105(10):1240-6. PubMed ID: 4162844
[No Abstract] [Full Text] [Related]
92. [Hormonal treatment benign prostatic hyperplasia. A review].
Schoonees R; de Klerk JN
S Afr Med J; 1972 Sep; 46(37):1337-9. PubMed ID: 4118059
[No Abstract] [Full Text] [Related]
93. Longitudinal evaluation of serum androgen levels in men with and without prostate cancer.
Carter HB; Pearson JD; Metter EJ; Chan DW; Andres R; Fozard JL; Rosner W; Walsh PC
Prostate; 1995 Jul; 27(1):25-31. PubMed ID: 7541528
[TBL] [Abstract][Full Text] [Related]
94. [Sexual repercussions of prostatic adenoma surgery for the man and his partner. Role of retrograde ejaculation].
Gellman R; Gellman-Barroux C
Ann Urol (Paris); 1998; 32(6-7):329-32. PubMed ID: 9922837
[TBL] [Abstract][Full Text] [Related]
95. [Topical use of thrombin in prostatic surgery].
Suzuki R; Matsuhashi M; Kuwahara T; Kase T
Hinyokika Kiyo; 1986 Oct; 32(10):1461-4. PubMed ID: 2436462
[TBL] [Abstract][Full Text] [Related]
96. [The importance of steroid and pituitary hormones in prostatic diseases. Discussion of a study].
Bouffioux C
Acta Urol Belg; 1980 Oct; 48(4):445-51. PubMed ID: 6779514
[No Abstract] [Full Text] [Related]
97. Suppressive effects of surgical stress on circulating androgens during and after prostatectomy.
Ghanadian R; Puah CM; Williams G; Shah PJ; McWhinney N
Br J Urol; 1981 Apr; 53(2):147-9. PubMed ID: 6165423
[TBL] [Abstract][Full Text] [Related]
98. Benign prostatic hyperplasia.
Chisholm GD; Khan MS
Practitioner; 1992 Mar; 236(1512):325-7. PubMed ID: 1378611
[No Abstract] [Full Text] [Related]
99. Clinical significance of interruption of therapy with allylestrenol in patients with benign prostatic hypertrophy.
Noguchi K; Harada M; Masuda M; Takeda M; Kinoshita Y; Fukushima S; Miyai K; Fukuoka H; Hosaka M
Int J Urol; 1998 Sep; 5(5):466-70. PubMed ID: 9781436
[TBL] [Abstract][Full Text] [Related]
100. Laparoscopic prostatectomy with vascular control for benign prostatic hyperplasia.
Mariano MB; Graziottin TM; Tefilli MV
J Urol; 2002 Jun; 167(6):2528-9. PubMed ID: 11992078
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
